TY  - JOUR

T1  - Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group Study

JO  - BREAST CANCER RES TR

PY  - 2010/08/01

AU  - Mansi JL

AU  - Yellowlees A

AU  - Lipscombe J

AU  - Earl HM

AU  - Cameron DA

AU  - Coleman RE

AU  - Perren T

AU  - Gallagher CJ

AU  - Quigley M

AU  - Crown J

AU  - Jones AL et al

ED  - 

DO  - DOI: 10.1007/s10549-010-0989-6

VL  - 122

IS  - 3

SP  - 787

EP  - 794

Y2  - 2025/10/10

ER  -